TrialPath
Anxiety · Seattle

Anxiety clinical trials in Seattle

4 recruiting anxiety disorder studies within range of Seattle. Click any trial for full eligibility criteria and contact info.

Individual Factors of CBT Underlying Success

NCT06678295 · Social Anxiety Disorder, Body Dysmorphic Disorder
Recruiting

The purpose of this study is to understand why some individuals respond fully to cognitive behavioral therapy and others do not, based on multiple sources of data such as neural, neurocognitive, clinical, and self-report data.

PhaseNA
TypeInterventional
Age18 Years – 45 Years
WhereSeattle, Washington, United States
SponsorUniversity of Washington
▾Tap for details
Apply

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

NCT07048574 · Cystic Fibrosis (CF)
Recruiting

This is a longitudinal, observational epidemiological study designed to estimate the prevalence of depression, anxiety, and behavior problems in children ages 18 months through 11 years with cystic fibrosis (CF).

Phase—
TypeObservational
Age18 Months – 11 Years
WhereOrange, California, United States + 12 more
SponsorState University of New York at Buffalo
▾Tap for details
Apply

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

NCT07002034 · Adjustment Disorder
Recruiting

The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in participants with Adjustment Disorder due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson's Disease (PD) or Idiopathic Pulmonary Fibrosis (IPF) as compared to active-placebo.

PhasePhase 2
TypeInterventional
Age18 Years – 80 Years
WhereBirmingham, Alabama, United States + 32 more
SponsorReunion Neuroscience Inc
▾Tap for details
Apply

Morphine or Ketamine for Analgesia

NCT06835504 · Abdominal Pain, Isolated Extremity Fracture, Pain
Recruiting

Pain is common in children presenting to the emergency department but is frequently undertreated, leading to both short- and long-term consequences. Morphine is the standard treatment for children with moderate to severe acute pain, but its use is associated with serious side effects and caregiver and clinician concerns related to opioid administration. The investigators aim to determine if sub-dissociative ketamine is non-inferior to morphine for treating acute pain and a preferable alternative for treating acute pain in children because of its more favorable side effect profile and potential long-term benefits related to pain-related function, analgesic use/misuse, and mental and behavioral health outcomes.

PhasePhase 3
TypeInterventional
Age6 Years – 17 Years
WhereLos Angeles, California, United States + 7 more
SponsorColumbia University
▾Tap for details
Apply